Big Gain For Solid Biosciences Inc.
Fri, Dec 11, 2020 at 05:33 PM
Solid Biosciences Inc. (SLDB:NASDAQ) rocketted at $5.61, a gain of 51.6%. The stock got featured on our News Catalysts scanner on Fri 11 Dec 20 at 03:25 PM in the 'ACQUISITION' category. From Fri 27 Nov 20, the stock recorded 66.67% Up Days and 60.00% Green Days
The stock spiked on Thu 01 Oct 20 at $6.1 with a volume of 193M+, and its share price has been moving sideways in recent weeks.
About Solid Biosciences Inc. (SLDB:NASDAQ)
Solid Biosciences Inc is a life science company engaged in developing therapies for Duchenne muscular dystrophy. Its product candidate, SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles.
Top 10 Gainers:
- TPGY (TPGY:NYSE), 116.22%
- MACU (MACU:NASDAQ), 100%
- Solid Biosciences Inc. (SLDB:NASDAQ), 51.62%
- Equus Total Return, Inc. (EQS:NYSE), 46.9%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 42.65%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 41.55%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 41.29%
- NextDecade Corporation (NEXT:NASDAQ), 38%
- Recro Pharma, Inc. (REPH:NASDAQ), 36.81%
- FAT Brands Inc. (FAT:NASDAQ), 28.08%